Study Examines Impact of Unintended Pregnancy Among Active-Duty Soldiers
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, July 26, 2024 -- Estimates of unintended pregnancy (UIP) among active-duty service women (ADSW) indicate a considerable impact on the ability to meet Women, Peace, and Security objectives, according to a study published online July 25 in BMJ Military Health.
Miranda Lynn Janvrin, from the Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. in Bethesda, Maryland, and colleagues estimated the number of UIPs among ADSW in the United States and examined the impact of these pregnancies on the ability to meet Women, Peace, and Security objectives as measured by maximum potential readiness days lost (mRDL). The number of UIPs was estimated by multiplying both the number of ADSW and the number of deliveries by age-adjusted rates of UIP. In fiscal year 2019, 230,596 ADSW were identified.
The researchers found that an estimated 12,683 ADSW experienced an UIP using the number of ADSW, resulting in an estimated 4,629,215 mRDL. An estimated 6,785 deliveries were the result of UIPs using the number of deliveries, yielding an estimated 2,476,364 mRDL. Estimates of UIPs were highest for those aged 18 to 24 years, Whites, those in a Junior Enlisted rank, and those in the Army.
"Dealing with UIPs proactively by encouraging comprehensive family planning and instituting additional reproductive health policies promoting, sex education and contraceptive options for service members would improve women's ability to meaningfully participate to meet the Department of Defense's Women, Peace, and Security objectives by ensuring that active-duty service members can make informed decisions about their reproductive health while maintaining operational effectiveness," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-27 07:15
Read more
- Small but Important Differences Seen Between Rosuvastatin, Atorvastatin
- Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases
- Fine Particulate Matter Linked to Increased Incidence of Head, Neck Cancer
- Younger Patients More Affected by Neurologic Manifestations of Long COVID
- U.S. Postpartum Depression Diagnoses Doubled in a Decade
- Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions